Update on Disruption in Operations at some of the manufacturing sites at Haridwar
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Akums Drugs and Pharmaceuticals experienced a disruption at some of its Haridwar manufacturing sites due to industry-wide labour unrest. The unrest, triggered by state authorities reviewing minimum wages in Uttarakhand, affected not just the pharmaceutical sector but all major industrial towns in the state. Over 70% of operations have successfully resumed from 16th May 2026, with progressive improvement expected. There is no damage to company property, and the production loss is covered under an industrial insurance policy. Other manufacturing locations remained stable and continued as usual.
Short-term production disruption has occurred but operations are recovering with 70%+ capacity already restored. Insurance coverage provides some financial protection, and the resumption of work is a positive signal for investors. However, full recovery and the extent of financial impact are still being assessed.